All the latest news on the marijuana space delivered directly to your inbox.
Read our Medical Marijuana Compound Report for Free Today!
The next big innovation is unfolding now and it’s already creating a wave of multi-millionaire investors in the process

13x13x1 READ MORE
Read the Investors Guide To Newly Emerging Marijuana Markets 
Maricann Group Inc. Signs Letter of Intent with Lovell Drugs

Maricann announces that it has entered into a letter of intent with Lovell Drugs Limited ("Lovell Drugs"), one of the oldest independent drug store chains in Ontario, to be the primary and exclusive provider of medicinal cannabis products to its patients

13x13x1 READ MORE
greenRush Closes $3.6 Million Series A Funding Round

The Amazon of Cannabis Set to Expand Recreational & Medical Marijuana Services in California, Nevada, Massachusetts, Maryland, New York, Pennsylvania, Illinois and More

13x13x1 READ MORE
Gotham Green Partners and Co-Investors Close Out Steep Hill's Series III Convertible Notes

Steep Hill Labs, Inc. and Gotham Green Partners announced today that funds managed by Gotham Green and co-investor Slifka Asset Management have invested Two and One-Half Million Dollars ($2.5M) into Steep Hill, completing Steep Hill's Series III Convertible Notes funding round.

13x13x1 READ MORE
Please see full disclaimers on the website applicable to all content provided by TSI, wherever published or re-published:

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 
32x32x1   32x32x2
9375 E Shea Blvd Ste 100
Scottsdale 85260
©2019, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.